Intermolecular (NASDAQ:IMI) Posts Earnings Results, Misses Estimates By $0.08 EPS

Intermolecular (NASDAQ:IMI) issued its earnings results on Thursday. The semiconductor company reported ($0.11) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.08), Bloomberg Earnings reports. Intermolecular had a negative net margin of 42.74% and a negative return on equity of 31.51%. The business had revenue of $4.62 million during the quarter.

Shares of IMI stock remained flat at $$1.18 during mid-day trading on Friday. 35,492 shares of the stock were exchanged, compared to its average volume of 162,901. The business’s 50-day moving average price is $1.17. Intermolecular has a fifty-two week low of $0.88 and a fifty-two week high of $1.42. The company has a debt-to-equity ratio of 0.38, a quick ratio of 5.84 and a current ratio of 5.84.

IMI has been the topic of a number of research reports. ValuEngine raised shares of Intermolecular from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Lake Street Capital downgraded shares of Intermolecular from a “buy” rating to a “hold” rating in a research note on Monday, May 6th.

About Intermolecular

Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.

Featured Article: How is the Producer Price Index calculated?

Earnings History for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.